These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2129232)

  • 1. Biological reactive intermediates of bisfuranoid mycotoxins.
    Hsieh DP
    J Toxicol Sci; 1990 Dec; 15 Suppl 4():152-8. PubMed ID: 2129232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisfuranoid mycotoxins: their genotoxicity and carcinogenicity.
    Hsieh DP; Atkinson DN
    Adv Exp Med Biol; 1991; 283():525-32. PubMed ID: 1906226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA adducts of aflatoxins, sterigmatocystin and other mycotoxins.
    McConnell IR; Garner RC
    IARC Sci Publ; 1994; (125):49-55. PubMed ID: 7806340
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of rates of enzymatic oxidation of aflatoxin B1, aflatoxin G1, and sterigmatocystin and activities of the epoxides in forming guanyl-N7 adducts and inducing different genetic responses.
    Baertschi SW; Raney KD; Shimada T; Harris TM; Guengerich FP
    Chem Res Toxicol; 1989; 2(2):114-2. PubMed ID: 2519710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical and physical properties of the major serum albumin adduct of aflatoxin B1 and their implications for the quantification in biological samples.
    Sabbioni G
    Chem Biol Interact; 1990; 75(1):1-15. PubMed ID: 2114222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidation of aflatoxins and sterigmatocystin by human liver microsomes: significance of aflatoxin Q1 as a detoxication product of aflatoxin B1.
    Raney KD; Shimada T; Kim DH; Groopman JD; Harris TM; Guengerich FP
    Chem Res Toxicol; 1992; 5(2):202-10. PubMed ID: 1643250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological reactive intermediates of mycotoxins.
    Hsieh DP
    Adv Exp Med Biol; 1986; 197():597-610. PubMed ID: 3094340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of versicolorin A, a genotoxic precursor of aflatoxin B1: Characterization of metabolites using in vitro production of standards.
    Al-Ayoubi C; Oules J; Person E; Bruel S; Bouville A; Pinton P; Oswald IP; Jamin EL; Puel O; Soler L
    Food Chem Toxicol; 2022 Sep; 167():113272. PubMed ID: 35803361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative carcinogenesis and dosimetry in rainbow trout for aflatoxin B1 and aflatoxicol, two aflatoxins that form the same DNA adduct.
    Bailey GS; Loveland PM; Pereira C; Pierce D; Hendricks JD; Groopman JD
    Mutat Res; 1994 Aug; 313(1):25-38. PubMed ID: 7519308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantum-chemical studies of aflatoxin B1, sterigmatocystin and versicolorin A, and a comparison with their mutagenic activity.
    Pachter R; Steyn PS
    Mutat Res; 1985; 143(1-2):87-91. PubMed ID: 3923331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycotoxins: food contamination, mechanism, carcinogenic potential and preventive measures.
    Chu FS
    Mutat Res; 1991; 259(3-4):291-306. PubMed ID: 2017214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum albumin adducts in the molecular epidemiology of aflatoxin carcinogenesis: correlation with aflatoxin B1 intake and urinary excretion of aflatoxin M1.
    Gan LS; Skipper PL; Peng XC; Groopman JD; Chen JS; Wogan GN; Tannenbaum SR
    Carcinogenesis; 1988 Jul; 9(7):1323-5. PubMed ID: 3133131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rainbow trout (Salmo gairdneri) embryos: a sensitive animal model for experimental carcinogenesis.
    Hendricks JD; Wales JH; Sinnhuber RO; Nixon JE; Loveland PM; Scanlan RA
    Fed Proc; 1980 Dec; 39(14):3222-9. PubMed ID: 7439406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotoxicity of aflatoxins and their precursors in human cells.
    Theumer MG; Henneb Y; Khoury L; Snini SP; Tadrist S; Canlet C; Puel O; Oswald IP; Audebert M
    Toxicol Lett; 2018 May; 287():100-107. PubMed ID: 29421331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA damage by mycotoxins.
    Wang JS; Groopman JD
    Mutat Res; 1999 Mar; 424(1-2):167-81. PubMed ID: 10064859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological detection of aflatoxin B1-DNA adducts formed in vivo.
    Hsieh LL; Hsu SW; Chen DS; Santella RM
    Cancer Res; 1988 Nov; 48(22):6328-31. PubMed ID: 3141043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathology of mycotoxicosis (author's transl)].
    Enomoto M; Ohtsubo K; Takenaka S
    Tanpakushitsu Kakusan Koso; 1976 Nov; Suppl():325-38. PubMed ID: 194284
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of the isolated perfused rat liver to study carcinogen-DNA adduct formation from aflatoxin B1 and sterigmatocystin.
    Essigmann JM; Donahue PR; Story DL; Wogan GN; Brunengraber H
    Cancer Res; 1980 Nov; 40(11):4085-91. PubMed ID: 6781740
    [No Abstract]   [Full Text] [Related]  

  • 19. Aflatoxin B1-2,3-oxide as a probable intermediate in the covalent binding of aflatoxins B1 and B2 to rat liver DNA and ribosomal RNA in vivo.
    Swenson DH; Lin JK; Miller EC; Miller JA
    Cancer Res; 1977 Jan; 37(1):172-81. PubMed ID: 187331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative mutagenicity of palmotoxin Bo and aflatoxins B1 and M1.
    Uwaifo AO; Emerole GO; Bababunmi EA; Bassir O
    J Environ Pathol Toxicol; 1979; 2(4):1099-107. PubMed ID: 109559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.